Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study

BACKGROUND: Malignancy risk with tumour necrosis factor inhibitor (TNFi) therapy remains unclear. Our primary aim was to assess malignancy risk with TNFi therapy in a cohort of Australian patients with rheumatoid arthritis (RA). We also assessed risk in a biologic-naïve group. METHODS: Demographic d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Musculoskelet Disord
Main Authors: Buchbinder, Rachelle, Van Doornum, Sharon, Staples, Margaret, Lassere, Marissa, March, Lyn
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4615333/
https://ncbi.nlm.nih.gov/pubmed/26481039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-015-0772-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados